跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/IRCT20170614034532N2
IRCT20170614034532N2尚未招募3 期

Comparing efficacy and safety of Colistin Loading dose regimen versus Conventional regimen in improving clinical and microbiological response for the treatment of multidrug resistant gram-negative infections in pediatrics

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
3 期
状态
尚未招募
入组人数
40
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 month 至 18 years（—）
性别
All

入选标准

  • •Colistin receiving for at least four days
  • •Normal baseline renal status before administration of Colistin
  • •Children from 1 month to 18 years
  • •Children with a positive blood culture or VAP
  • •Gram negative culture which is only susceptible to Colistin

排除标准

  • •Parents Dissatisfaction
  • •Receiving Nebulized form of Colistin for VAP
  • •Receiving antibiotics effective on gram negative micro organisms other than Colistin and Meropenem

研究者

相似试验

招募中
不适用
Efficacy and safety of Colistin plus high dose ampicillin/sulbactam vs. colistin monotherapy for the treatment of carbapenem resistant Acinetobacter baumannii (CRAB) bacteremia: a multicenter, open-label, randomized controlled trial
KCT0008158Seoul National University Bundang Hospital72
已完成
不适用
Clinical research on the effectiveness of colistin against mulch drug resistant gram negative bacterial infectiomulch drug resistant gram negative bacterial infection
JPRN-UMIN000015503Chiba University5
尚未招募
2 期
Comparison of colistin / levofloxacin combination with colistin / meropenem combination in the treatment of ventilator-dependent upper respiratory tract (VAP) induced by Acinetobacter: a randomized controlled clinical trial
IRCT20150721023282N17Esfahan University of Medical Sciences42
招募中
3 期
ebulized colistin in pneumonia
IRCT20190616043906N1Tehran University of Medical Sciences42
已完成
不适用
An exploratory study of administration of colistin for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.
JPRN-UMIN000002122niversity of Tokyo Hospital Department of Hamatology and Oncology5